X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ALEMBIC PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ALEMBIC PHARMA ALEMBIC LTD/
ALEMBIC PHARMA
 
P/E (TTM) x 63.1 14.6 432.3% View Chart
P/BV x 2.5 3.6 70.7% View Chart
Dividend Yield % 0.4 1.1 37.8%  

Financials

 ALEMBIC LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
ALEMBIC PHARMA
Mar-19
ALEMBIC LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs72664 10.8%   
Low Rs34412 8.2%   
Sales per share (Unadj.) Rs4.7208.7 2.3%  
Earnings per share (Unadj.) Rs6.131.0 19.7%  
Cash flow per share (Unadj.) Rs6.237.1 16.8%  
Dividends per share (Unadj.) Rs0.205.50 3.6%  
Dividend yield (eoy) %0.41.0 37.0%  
Book value per share (Unadj.) Rs40.7144.2 28.2%  
Shares outstanding (eoy) m267.03188.52 141.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.6 436.8%   
Avg P/E ratio x8.717.4 50.0%  
P/CF ratio (eoy) x8.514.5 58.5%  
Price / Book Value ratio x1.33.7 34.9%  
Dividend payout %3.317.7 18.5%   
Avg Mkt Cap Rs m14,139101,461 13.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2077,467 2.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25539,347 3.2%  
Other income Rs m37094 394.7%   
Total revenues Rs m1,62539,441 4.1%   
Gross profit Rs m1118,736 1.3%  
Depreciation Rs m381,152 3.3%   
Interest Rs m2184 0.9%   
Profit before tax Rs m4427,493 5.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1,212-93 -1,306.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,568 1.5%   
Profit after tax Rs m1,6305,844 27.9%  
Gross profit margin %8.922.2 39.9%  
Effective tax rate %5.420.9 25.9%   
Net profit margin %129.814.9 874.3%  
BALANCE SHEET DATA
Current assets Rs m1,86719,577 9.5%   
Current liabilities Rs m59114,896 4.0%   
Net working cap to sales %101.611.9 854.4%  
Current ratio x3.21.3 240.3%  
Inventory Days Days9490 105.0%  
Debtors Days Days7445 162.2%  
Net fixed assets Rs m1,79127,097 6.6%   
Share capital Rs m534377 141.7%   
"Free" reserves Rs m10,32426,811 38.5%   
Net worth Rs m10,85827,188 39.9%   
Long term debt Rs m414,993 0.8%   
Total assets Rs m11,59147,778 24.3%  
Interest coverage x260.941.7 625.6%   
Debt to equity ratio x00.2 2.1%  
Sales to assets ratio x0.10.8 13.1%   
Return on assets %14.112.6 111.6%  
Return on equity %15.021.5 69.8%  
Return on capital %15.223.6 64.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1919,453 0.1%   
Fx outflow Rs m2646,065 4.4%   
Net fx Rs m-24413,388 -1.8%   
CASH FLOW
From Operations Rs m2368,120 2.9%  
From Investments Rs m-224-7,556 3.0%  
From Financial Activity Rs m-27590 -4.5%  
Net Cashflow Rs m-151,153 -1.3%  

Share Holding

Indian Promoters % 64.0 74.1 86.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 2.9 6.9%  
FIIs % 9.7 9.1 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 13.9 187.8%  
Shareholders   54,701 49,328 110.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   FDC LTD.  FULFORD INDIA  WYETH LTD  AJANTA PHARMA  UNICHEM LAB  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Erase Gains; Sensex Ends 52 Points Higher(Closing)

After opening the day higher, Indian share markets witnessed negative trading activity during closing hours and ended their trading session marginally higher.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 80.6% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 80.6% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

My Top 3 Dividend Millionaire Stocks(Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 19, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - SUVEN LIFESCIENCES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS